CUAMC
CTNM

China Universal Asset Management Company’s Contineum Therapeutics CTNM Stock Holding History

China Universal Asset Management Company’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
11,208
-2,295
-17% -$30.1K 0.01% 360
2026
Q1 		$176K Buy
13,503
+9,739
+259% +$131K 0.01% 361
2025
Q4 		$43K Buy
+3,764
New +$42.9K ﹤0.01% 463

Other funds holding CTNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

China Universal Asset Management Company's CTNM Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Contineum Therapeutics (CTNM) stake by 17% in Q2 2026, selling an estimated $30.1K and leaving 11,208 shares worth $184K. The position accounts for 0.01% of the portfolio, ranked #360.

China Universal Asset Management Company first reported a position in CTNM in Q4 2025 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • China Universal Asset Management Company held 11,208 shares of Contineum Therapeutics worth $184K as of Q2 2026.
  • China Universal Asset Management Company sold 2,295 Contineum Therapeutics shares in Q2 2026, an estimated $30.1K.
  • Contineum Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #360 holding.
  • China Universal Asset Management Company first reported a position in Contineum Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.